| Perpetrators of pharmacokinetic drug–drug interactions arising from altered cytochrome P450 activity: a criteria‐based assessment TM Polasek, FPY Lin, JO Miners, MP Doogue British journal of clinical pharmacology 71 (5), 727-736, 2011 | 124 | 2011 |
| Computational bacterial genome-wide analysis of phylogenetic profiles reveals potential virulence genes of Streptococcus agalactiae FPY Lin, R Lan, V Sintchenko, GL Gilbert, F Kong, E Coiera PLoS One 6 (4), e17964, 2011 | 41 | 2011 |
| Topological barrier to Cas12a activation by circular DNA nanostructures facilitates autocatalysis and transforms DNA/RNA sensing F Deng, Y Li, B Yang, R Sang, W Deng, M Kansara, F Lin, ... Nature Communications 15 (1), 1818, 2024 | 38 | 2024 |
| Computational prediction of multidisciplinary team decision-making for adjuvant breast cancer drug therapies: a machine learning approach FPY Lin, A Pokorny, C Teng, R Dear, RJ Epstein BMC Cancer 16, 929, 2016 | 35 | 2016 |
| A practical decision‐tree model to predict complexity of reconstructive surgery after periocular basal cell carcinoma excision E Tan, F Lin, L Sheck, P Salmon, S Ng Journal of the European Academy of Dermatology and Venereology 31 (4), 717-723, 2017 | 27 | 2017 |
| Growth of periocular basal cell carcinomas E Tan, FPY Lin, LHN Sheck, PJ Salmon, SGJ Ng British Journal of Dermatology 172 (4), 1002-1007, 2015 | 27 | 2015 |
| Cancer care treatment outcome ontology: a novel computable ontology for profiling treatment outcomes in patients with solid tumors FP Lin, T Groza, S Kocbek, E Antezana, RJ Epstein JCO clinical cancer informatics 2, 1-14, 2018 | 21* | 2018 |
| TEPAPA: a novel in silico feature learning pipeline for mining prognostic and associative factors from text-based electronic medical records FPY Lin, A Pokorny, C Teng, RJ Epstein Scientific Reports 7, 6918, 2017 | 21 | 2017 |
| How aging of the global population is changing oncology YF Gu, FP Lin, RJ Epstein ecancermedicalscience 15, ed119, 2021 | 19 | 2021 |
| Cancer and the omics revolution RJ Epstein, FP Lin Aust Fam Physician 46 (4), 189-193, 2017 | 18 | 2017 |
| Limited clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D‐CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials LJ Zeverijn, EJ Looze, S Thavaneswaran, JM van Berge Henegouwen, ... International Journal of Cancer 153 (7), 1413-1422, 2023 | 15 | 2023 |
| A PubMed-wide associational study of infectious diseases V Sintchenko, S Anthony, XH Phan, F Lin, EW Coiera PLoS One 5 (3), e9535, 2010 | 15 | 2010 |
| Early circulating tumor DNA dynamics as a pan‐tumor biomarker for long‐term clinical outcome in patients treated with durvalumab and tremelimumab M Kansara, N Bhardwaj, S Thavaneswaran, C Xu, JK Lee, LB Chang, ... Molecular Oncology 17 (2), 298-311, 2023 | 11 | 2023 |
| Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology FP Lin, S Thavaneswaran, JP Grady, M Ballinger, M Kansara, SR Oakes, ... NPJ Precision Oncology 5 (1), 58, 2021 | 10 | 2021 |
| A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations S Thavaneswaran, M Kansara, F Lin, D Espinoza, JP Grady, CK Lee, ... British Journal of Cancer 129 (3), 475-485, 2023 | 9 | 2023 |
| Commonly used molecular epidemiology markers of Streptococcus agalactiae do not appear to predict virulence F Lin, V Sintchenko, F Kong, GL Gilbert, E Coiera Pathology 41 (6), 576-581, 2009 | 9 | 2009 |
| Development and validation of a deep learning model for improving detection of nonmelanoma skin cancers treated with Mohs micrographic surgery E Tan, S Lim, D Lamont, R Epstein, D Lim, FPY Lin JAAD international 14, 39-47, 2024 | 8 | 2024 |
| BICEPP: an example-based statistical text mining method for predicting the binary characteristics of drugs FPY Lin, S Anthony, TM Polasek, G Tsafnat, MP Doogue BMC bioinformatics 12, 1-13, 2011 | 8 | 2011 |
| The experiences and needs of Australian medical oncologists in integrating comprehensive genomic profiling into clinical care: a nation-wide survey S Thavaneswaran, M Ballinger, P Butow, B Meiser, D Goldstein, F Lin, ... Oncotarget 12 (21), 2169, 2021 | 7 | 2021 |
| Tumor size is not everything: advancing radiomics as a precision medicine biomarker in oncology drug development and clinical care. A report of a multidisciplinary workshop … EC Nakajima, A Simpson, J Bogaerts, EGE de Vries, R Do, E Garralda, ... JCO Precision Oncology 8, e2300687, 2024 | 6 | 2024 |
